Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients
Clinical trial NCT02024477 · COMPLETED
Trial details
- NCT number
- NCT02024477
- Sponsor
- George Washington University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2017-09-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.